MMSI vs. CMD, NUVA, ATRC, SILK, COO, XRAY, HAE, NEOG, QDEL, and ICUI
Should you be buying Merit Medical Systems stock or one of its competitors? The main competitors of Merit Medical Systems include Cantel Medical (CMD), NuVasive (NUVA), AtriCure (ATRC), Silk Road Medical (SILK), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), Neogen (NEOG), QuidelOrtho (QDEL), and ICU Medical (ICUI). These companies are all part of the "medical" sector.
Cantel Medical (NYSE:CMD) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk, institutional ownership and community ranking.
In the previous week, Merit Medical Systems had 15 more articles in the media than Cantel Medical. MarketBeat recorded 15 mentions for Merit Medical Systems and 0 mentions for Cantel Medical. Cantel Medical's average media sentiment score of 0.87 beat Merit Medical Systems' score of 0.00 indicating that Merit Medical Systems is being referred to more favorably in the news media.
Merit Medical Systems has a consensus target price of $92.78, suggesting a potential upside of 13.36%. Given Cantel Medical's higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than Cantel Medical.
Merit Medical Systems has a net margin of 7.94% compared to Merit Medical Systems' net margin of 4.72%. Cantel Medical's return on equity of 15.02% beat Merit Medical Systems' return on equity.
84.1% of Cantel Medical shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 10.7% of Cantel Medical shares are owned by company insiders. Comparatively, 3.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Merit Medical Systems received 201 more outperform votes than Cantel Medical when rated by MarketBeat users. Likewise, 68.90% of users gave Merit Medical Systems an outperform vote while only 65.53% of users gave Cantel Medical an outperform vote.
Merit Medical Systems has higher revenue and earnings than Cantel Medical. Merit Medical Systems is trading at a lower price-to-earnings ratio than Cantel Medical, indicating that it is currently the more affordable of the two stocks.
Cantel Medical has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500.
Summary
Merit Medical Systems beats Cantel Medical on 14 of the 17 factors compared between the two stocks.
Get Merit Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Merit Medical Systems Competitors List
Related Companies and Tools
